Physician

Michael William Lenihan, M.D.

According to 2025 Medicare claims, Michael Lenihan, M.D. (NPI: 1285727792) practices neurology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Saratoga, NY. This provider's primary affiliated billing organization is ADIRONDACK NEUROLOGY ASSOCIATES, PC (NPI: 1861585549; TIN: 141725807) and primary practice location at 12801-2929. Lenihan is affiliated with the Adirondacks ACO, LLC (ACO ID: A2193), participating under the MSSP model.

Lenihan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 713 traditional Medicare patients, billed 47,068 HCPCS/CPT codes, and received $1,383,357 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 5,732 prescription claims across 663 beneficiaries totaling $1,942,325 in drug costs, led by Gammaked (Immune Globul G/Gly/Iga Avg 46). 2017 DME data shows 11 claims. Open Payments data shows 69 records totaling $19,681. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $137,403 to $1,383,357. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	834	5,415	$137,403
2016	1,125	4,422	$147,736
2017	722	3,337	$101,221
2018	707	5,182	$154,835
2019	894	12,452	$364,248
2020	898	23,150	$642,506
2021	791	18,272	$742,871
2022	788	17,947	$719,535
2023	761	26,726	$1,162,007
2024	713	47,068	$1,383,357

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	397	2,320	$1,138,394
2016	484	3,875	$1,490,481
2017	494	4,537	$2,073,754
2018	483	4,834	$2,192,909
2019	403	3,634	$1,941,913
2020	402	3,149	$2,047,565
2021	442	3,221	$2,177,939
2022	546	4,647	$2,074,277
2023	578	4,927	$1,942,814
2024	663	5,732	$1,942,325

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$289
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	147	147	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	394	584	$77
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	34	53	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	65	73	$49
93880	Ultrasound of both sides of head and neck blood flow	111	111	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammaked	Immune Globul G/Gly/Iga Avg 46	38	916	$322,515
Ingrezza	Valbenazine Tosylate	28	817	$220,826
Teriflunomide	Teriflunomide	70	2,100	$120,256
Kesimpta Pen	Ofatumumab	12	336	$105,920
Vimpat	Lacosamide	73	2,190	$84,293

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	69	$19,681	Eisai Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael William Lenihan, M.D.?

Tedicare shows public-source Medicare data for Michael William Lenihan, M.D. (NPI 1285727792), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael William Lenihan, M.D. have ACO affiliation data?

Michael William Lenihan, M.D. is shown with ACO affiliation data for Adirondacks ACO, LLC (MSSP, ACO ID A2193).

What billing organization is linked to Michael William Lenihan, M.D.?

Michael William Lenihan, M.D. is linked to ADIRONDACK NEUROLOGY ASSOCIATES, PC (billing NPI 1861585549) in the available physician profile data.

Does Michael William Lenihan, M.D. have Open Payments data?

Michael William Lenihan, M.D. has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.